Loss per Common Share

The computation of basic net loss per share is based on the weighted average number of common shares outstanding for the years ended December 31, 2017, 2016 and 2015. The Company also had 3,040,540 outstanding warrants convertible to 152,027 shares of the Company's common stock with an exercise price of $556.40 per share. The warrants have a 7 year term and will expire on October 15, 2021. Diluted net loss per share gives effect to stock awards, stock options and restricted stock units using the treasury stock method, unless the impact is anti-dilutive. Diluted net loss per share for the year ended December 31, 2017 does not include 1,716,928 unvested stock awards, 2,301,046 stock options and outstanding warrants convertible to 152,027 shares of common stock as their effect was anti-dilutive. Diluted net loss per share for the year ended December 31, 2016 does not include 1,413,461 unvested stock awards, 1,942,909 stock options and outstanding warrants convertible into 152,027 shares of common stock as their effect was anti-dilutive. Diluted net loss per share for the year ended December 31, 2015 does not include 39,231 stock awards, 68,867 stock options and outstanding warrants convertible into 152,027 shares of common stock, as their effect was anti-dilutive.



	For the Years Ended
	December 31, 2017			December 31, 2016			December 31, 2015
Net loss	$	(43,796,685	)	$	(223,522,435	)	$	(148,296,965	)
Weighted Average Shares-Basic	69,182,302			20,565,652			1,880,116
Dilutive effect of stock options, warrants and restricted stock units	—			—			—
Weighted Average Shares - Diluted	69,182,302			20,565,652			1,880,116
Basic loss per share	$	(0.63	)	$	(10.87	)	$	(78.88	)
Diluted loss per share	$	(0.63	)	$	(10.87	)	$	(78.88	)